Pharmaceutical Products DPS
Titre original de l'avis
Bulgaria – Pharmaceutical products – ДСП „Доставка на лекарствени продукти“
Score d'opportunité
Pourquoi ce score ?
Opportunité
63 / 100
Complexité
72 / 100
Facteurs de risque
The DPS specification may be changed during its term, including new products and quantity changes.
Participation depends on holding specific wholesale, narcotics, and radioactive-substances authorisations where applica...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Informations clés
- Pouvoir adjudicateur
- КОМПЛЕКСЕН ОНКОЛОГИЧЕН ЦЕНТЪР - СТАРА ЗАГОРА ЕООД
- Pays
- Bulgarie
- CPV
- 33600000 - Pharmaceutical products
- Date limite
- Aug 31, 2027
- Valeur estimée
- BGN 300M
Aperçu
Moderate opportunityFaits clés
- BGN 300M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Supply of pharmaceutical products for the contracting authority's needs.
- Medicines for treatment of solid malignant diseases.
Afficher le résumé complet
This is a Bulgarian DPS for pharmaceutical products for the needs of the Complex Oncology Center - Stara Zagora. The notice is for supplies, restricted procedure, electronic submission required, with an estimated overall value of BGN 300,000,000. The DPS scope covers medicines for solid malignant diseases, medicines from the Positive Drug List for other diseases, non-PLS medicines, and radiopharmaceuticals. Procurement documents are linked, but only the TED XML notice text was provided; the underlying procurement documents were not analyzed.
Risques
The DPS specification may be changed during its term, including new products and quantity changes.
Participation depends on holding specific wholesale, narcotics, and radioactive-substances authorisations where applica...
Restricted procedure — pre-qualification required
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Procedure type is restricted.
- The DPS is open for pharmaceutical supply offers matching the product specification.
Administrative
- Electronic submission is required.
Critères d'attribution
Lot 1
Acheteur
Localisation
гр. Стара Загора, BGR
Site web
Profil acheteur
Identifiant
000812197
Activité
Health
Lots (1)
LOT-0001
Pharmaceutical Products DPS
Dynamic purchasing system for supply of pharmaceutical products for the contracting authority, including medicines for solid malignant diseases, medicines from the Positive Drug List for other diseases, medicines outside the Positive Drug List, and radiopharmaceuticals. Quantities in the initial specification are indicative and may be changed during the DPS, including adding new products or changing quantities. This lot information comes from the structured data and XML notice.
BGN 300M
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Най-ниска единична цена за всеки отделен лекарствен продукт (номенклатура) в лева с ДДС до пети знак след десетичната запетая.
Note sur la valeur
Afficher les données TED originales
Titre original du lot
ДСП „Доставка на лекарствени продукти“
Description TED originale
Динамичната система за покупки (ДСП) се създава за доставка на лекарствени продукти за нуждите на възложителя в т.ч. но не само на лекарствени продукти за лечение на солидни злокачествени заболявания, на лекарствени продукти от Позитивния лекарствен списък (ПЛС) за лечение на други заболявания, на лекарствени продукти извън ПЛС и на радиофармацевтици от ПЛС. В приложената към документацията първоначална „Спецификация на лекарствени продукти“ са посочени нужните лекарствени продукти и количествата им съобразно преценката на възложителя към момента на създаване на ДСП. Тези количества са прогнозни и не задължават Възложителя да ги възложи в пълния им обем. Спецификацията може да бъде променяна в хода на ДСП в това число да се добавят нови лекарствени продукти и/или да се променят количествата на лекарствени продукти.
Détails de la procédure
- Date de publication
- 29 Aug 2024
- Langues
- Bulgarian
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 521273-2024
Documents (1)
Appels d'offres similaires
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Score d'opportunité
Pourquoi ce score ?
Opportunité
63 / 100
Complexité
72 / 100
Facteurs de risque
The DPS specification may be changed during its term, including new products and quantity changes.
Participation depends on holding specific wholesale, narcotics, and radioactive-substances authorisations where applica...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications